Digital Health Startups

PERME is a deep-tech home-testing platform that converts biological samples into digital health information in real time using an affordable device that does not require a lab, then applies data analytics and AI/ML to generate personalized health recommendations and telehealth consultations. Operating a B2B2C model, it serves individuals and partners with corporations for anonymized user-data analytics in the healthcare and wellness sectors, with labs in the United States and Israel.

1 investor

Perry offers a holistic perimenopause support platform combining a peer community, evidence-based nutrition and emotional guidance, and access to women's health specialists. It serves women aged 40+ navigating perimenopause, and also runs a podcast, published journal, and a network for perimenopause-competent health professionals.

1 investor

Perry Health provides doctor-led diabetes management combining a personalized care plan, a connected blood glucose meter with delivered testing supplies, and regular check-ins with clinicians, dietitians and coaches. It serves people 26 and older with prediabetes or Type 1/Type 2 diabetes in the US, with services covered by Medicare Part B, Medicare Advantage and select commercial plans.

1 investor

Perseo Pharma is a biotech spin-off from the University of Applied Sciences in Basel, Switzerland, developing enzyme immobilization and bioconjugation technologies for therapeutic applications. The company focuses on creating novel platforms for drug delivery and enzyme-based therapies targeting inborn errors of metabolism and other rare diseases.

1 investor

Person Centred Software provides a suite of software products for the social care sector in the UK, including care management systems, medicines management, staff wellbeing tools, and communication platforms. The company serves care home providers, nursing homes, and residential care facilities to digitize operations and improve resident care quality.

1 investor

PPHC is a concierge primary care medical practice offering personalized, patient-centered medicine including preventive care, chronic disease management, diagnostics, and wellness services. Based near Wellesley in Greater Boston, Massachusetts, it serves patients seeking direct access to board-certified physicians and coordinated specialist care.

1 investor

Persuasive develops a platform technology for high-throughput analysis of extracellular vesicles (EVs) and is building a blood-based diagnostic test using an EV protein biomarker signature to identify chronic coronary syndrome in primary-care patients presenting with chest pain. The company, spun out with UMC Utrecht researchers, targets early diagnosis of stable angina to reduce unnecessary hospital referrals.

1 investor

Perth Radiological Clinic is a private diagnostic imaging provider offering radiological services to the Western Australian community using advanced technology and trained medical professionals.

1 investor

Perthera provides an AI-powered precision medicine platform for oncologists that analyzes multi-omic molecular data and patient medical history to match cancer patients with targeted therapy options. The platform delivers clinical decision support and real-world evidence to guide personalized cancer treatment.

1 investor

Petauri provides commercialization, market access, evidence generation, and strategic communications services to life sciences companies navigating the healthcare market. It helps clients demonstrate clinical and economic value and secure access with payers, health systems, and regulators.

1 investor

PeteHealth provides in-home physical therapy and custom-fit medical braces to patients, with coverage often available through Medicare and insurance plans. The company pairs licensed physical therapists with personalized bracing solutions aimed at injury recovery, post-surgical healing, and mobility improvement.

1 investor

Pflegetiger provides mobile outpatient care and nursing services (ambulante Pflege) for people in their own homes, including social counseling, everyday assistance, and home nursing. Operating in most districts of Berlin as part of the Stephanus organization, it also supports substitute care (Verhinderungspflege) arrangements.

1 investor

PflegeWelt.de is a German advisory portal for seniors, people needing care, and their relatives, offering information on organizing care, applying for care insurance benefits, and care aids. It also provides a monthly care-supplies package ("Pflege-Paket") handled via the care insurance fund and a price-comparison service for senior and medical supplies.

1 investor

PsychoGeriatric Services (PGS) provides on-site behavioral and mental health care—including psychiatric assessments, medication management, psychotherapy, and crisis intervention—for residents of skilled nursing homes and long-term care facilities. Operating since 1994, it serves over 300 long-term care facilities across Maryland, Pennsylvania, Virginia, New Jersey, and Washington DC.

1 investor

Phanova provides an operating system for longitudinal care designed for clinical practices to manage patient data and workflows. The company serves healthcare providers seeking integrated solutions for continuous patient care management.

1 investor

Pharma Pilot provides SMS, webchat, and automated phone systems for pharmacies to handle prescription orders, refills, consultation bookings, and vaccination appointments. The platform uses automation to reduce the burden on pharmacists and enable 24/7 order intake.

1 investor

Pharmacierge receives electronic prescriptions from private clinicians and delivers medication directly to patients via same-day delivery across London and beyond. The company operates a robotically-enabled dispensary and provides an e-prescribing platform connecting independent private medical practices with pharmacy services.

1 investor

Pharmatest provides preclinical research services for drug development, including cell culture assays and animal models for cancer and skeletal disease research. The company serves pharmaceutical, biotechnology, and nutraceutical companies developing therapeutics and phytopharmaceutical products.

1 investor

Phelcom offers Eyer2, a portable clinical-grade retinal camera that captures fundus and ocular surface images wirelessly from a handheld device for use in eye care practices. The device integrates with existing electronic health records systems and includes cloud storage capabilities for telemedicine workflows.

1 investor

Phelix AI is an AI automation platform for healthcare providers and clinics that handles administrative workflows such as fax triaging, phone answering, scheduling, referrals, prior authorization, intake, charting, and follow-ups. It offers document- and note-processing APIs that convert unstructured healthcare PDFs into structured data and integrate with EHR, RIS, and HIS systems, available in Canada and US regions.

1 investor

Phenomics Health builds a medication-response intelligence platform that combines high-complexity clinical laboratory testing, pharmacogenomics, pharmacometabolomics, and AI-enabled analytics to support precision prescribing and medication decisions. It serves clinicians, payors, providers, and life-sciences partners in the precision-medicine space.

1 investor

PhenoML provides enterprise-grade APIs that convert clinical text into normalized medical codes and structured FHIR data for HIPAA-regulated healthcare workflows. It serves providers, health tech companies, and biopharma with use cases including EHR integration, referral intake, medical billing/coding, prior authorization, and patient record summarization.

1 investor

Phenyx Health builds decision-making software for complex, multi-appointment and resource-intensive healthcare processes, using descriptive, predictive, and prescriptive analytics to standardize, automate, and optimize managerial decisions. Its tools, offered for cloud-based or on-premise deployment, target patients and clinical staff by integrating information across process silos.

1 investor

Phi Med Europe develops NerveCheck, a portable medical device for early diagnosis and quantification of peripheral neuropathy, particularly diabetic neuropathy, using quantitative sensory testing (QST) technology. The device delivers rapid, non-invasive assessment of small and medium nerve fiber function for healthcare professionals in clinical settings.

1 investor